AMTX vs TECH
Aemetis Inc (AMTX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Aemetis Inc (AMTX) is a specialty chemicals company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported AMTX revenue for 2023-12-31 was $77.2M. Net income was -$46.4M. Revenue was up 174.6% from 2022-12-31 to 2023-12-31. AMTX currently screens at market cap $158.3M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
AMTX currently screens at market cap $158.3M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the AMTX and TECH stock pages for the full models.
Not investment advice.